David Emerson Jorden, a major owner of Dipexium Pharmaceuticals, Inc. and Dipexium Pharmaceuticals, Inc.'s Acting Chief Financial Officer, recently acquired 32,727 shares of the company. The buys took place at $6.88 per share, on June 14, 2017. Jorden now owns 151,913 shares of the company. Jorden operates out of The Woodlands, TX. Some additional info was provided as follows:
Issued pursuant to a private placement in connection with the purchase of common stock in a registered direct offering.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Regulation FD - Jan. 8, 2018